Hyperthyroidism management during pregnancy and lactation (Review)

  • Authors:
    • Mihai Cristian Dumitrascu
    • Adina-Elena Nenciu
    • Sandru Florica
    • Catalin George Nenciu
    • Aida Petca
    • Răzvan-Cosmin Petca
    • Adrian Vasile Comănici
  • View Affiliations

  • Published online on: July 7, 2021     https://doi.org/10.3892/etm.2021.10392
  • Article Number: 960
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Thyroid dysfunction is a significant public health issue, affecting 5‑10 more women compared to men. The estimated incidence is up to 12% and only for women the treatment rises up to 4.3 billion dollars annually. Thyroid pathology can have a major impact on female fertility and it can only be detected when preconception tests are performed. Untreated or poorly treated hyperthyroidism in a mother can affect the fetal development and pregnancy outcome. Between 0.1 and 0.4% of the pregnancies are affected by clinical hyperthyroidism. Thyroid dysfunction is associated with higher rates of pregnancy loss. Hyperthyroidism can complicate fetal health problems intrauterinely and in the neonatal period. The TSH receptor is stimulated by TSH and HCG which has a similar structure. This can lead to gestational thyrotoxicosis. Hyperthyroidism can be treated with propylthiouracil or methimazole and in selected cases, surgical treatment or radioactive iodine can be chosen. In pregnancy, the most used treatment is represented by propylthiouracil which can be used from the first trimester. The aim of this review is to assess the current data regarding the impact of thyroid dysfunction on pregnancy and to synthesize the treatment options during pregnancy and lactation.
View References

Related Articles

Journal Cover

September-2021
Volume 22 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Dumitrascu MC, Nenciu A, Florica S, Nenciu CG, Petca A, Petca R and Comănici AV: Hyperthyroidism management during pregnancy and lactation (Review). Exp Ther Med 22: 960, 2021
APA
Dumitrascu, M.C., Nenciu, A., Florica, S., Nenciu, C.G., Petca, A., Petca, R., & Comănici, A.V. (2021). Hyperthyroidism management during pregnancy and lactation (Review). Experimental and Therapeutic Medicine, 22, 960. https://doi.org/10.3892/etm.2021.10392
MLA
Dumitrascu, M. C., Nenciu, A., Florica, S., Nenciu, C. G., Petca, A., Petca, R., Comănici, A. V."Hyperthyroidism management during pregnancy and lactation (Review)". Experimental and Therapeutic Medicine 22.3 (2021): 960.
Chicago
Dumitrascu, M. C., Nenciu, A., Florica, S., Nenciu, C. G., Petca, A., Petca, R., Comănici, A. V."Hyperthyroidism management during pregnancy and lactation (Review)". Experimental and Therapeutic Medicine 22, no. 3 (2021): 960. https://doi.org/10.3892/etm.2021.10392